DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $62,000 | +10.7% | 11,858 | 0.0% | 0.00% | – |
| Q3 2016 | $56,000 | +16.7% | 11,858 | 0.0% | 0.00% | – |
| Q2 2016 | $48,000 | -2.0% | 11,858 | -24.3% | 0.00% | – |
| Q1 2016 | $49,000 | -31.0% | 15,658 | 0.0% | 0.00% | – |
| Q4 2015 | $71,000 | -4.1% | 15,658 | 0.0% | 0.00% | – |
| Q3 2015 | $74,000 | -33.9% | 15,658 | 0.0% | 0.00% | – |
| Q2 2015 | $112,000 | -94.9% | 15,658 | -94.0% | 0.00% | – |
| Q1 2015 | $2,205,000 | -6.0% | 260,766 | +3.5% | 0.00% | – |
| Q4 2014 | $2,346,000 | +15.3% | 251,906 | +3.0% | 0.00% | – |
| Q3 2014 | $2,035,000 | -25.8% | 244,526 | +3.1% | 0.00% | – |
| Q2 2014 | $2,742,000 | -8.3% | 237,213 | +0.6% | 0.00% | – |
| Q1 2014 | $2,991,000 | +2.2% | 235,914 | -11.9% | 0.00% | – |
| Q4 2013 | $2,928,000 | +48.0% | 267,799 | +67.5% | 0.00% | – |
| Q3 2013 | $1,979,000 | -1.3% | 159,897 | +6.4% | 0.00% | – |
| Q2 2013 | $2,005,000 | – | 150,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
| DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
| Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
| Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
| Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
| Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
| HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
| Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |